Fmoc-Arg(Pmc)-OPfp is an Fmoc-protected, guanidinium-bearing arginine derivative used as an amino acid building block for peptide synthesis, where the side chain is substituted with a Pmc (2,2,5,7,8-pentamethylchroman-6-sulfonyl) protecting group and the carboxyl terminus is converted to an OPfp ester. The molecule contains an N-terminal Fmoc carbamate that masks the α-amino group, a Pmc-protected guanidine side chain that limits undesired side reactions during coupling, and an OPfp (pentafluorophenyl) ester that provides an activated carboxyl functionality for amide bond formation under appropriate conditions. In research workflows, it is employed to introduce a protected arginine residue with controlled chemoselectivity and to support stepwise assembly of peptides or peptide-related intermediates where orthogonal protection of the guanidinium group is required.
CAT No: CP26334
CAS No:136013-81-5
Synonyms/Alias:Fmoc-Arg(Pmc)-OPfp;136013-81-5
Fmoc-Arg(Pmc)-OPfp is an Fmoc-protected arginine derivative bearing a Pmc-protected guanidinium side chain and an activated OPfp ester at the carboxyl terminus, forming a chiral, peptide-coupling-ready amino acid building block. The molecule contains an aromatic fluorenylmethyloxycarbonyl (Fmoc) group for orthogonal N-protection, a Pmc (2,2,5,7,8-pentamethylchroman-6-sulfonyl) group that masks the strongly basic guanidine functionality, and an OPfp leaving group that supports efficient acyl transfer under peptide synthesis conditions. The stereogenic center of arginine is preserved, enabling stereochemically defined peptide bond formation and downstream structure-activity relationship studies. The combination of protected amine, protected side-chain guanidine, and activated carboxyl group yields a controlled reactivity profile suited to both protected amino acid chemistry and scalable peptide intermediate preparation.
1. Peptide Synthesis
Fmoc-Arg(Pmc)-OPfp is used in peptide synthesis workflows where an activated arginine carboxyl component is required for reliable coupling to a growing peptide chain. The Fmoc group provides an N-protection strategy compatible with standard deprotection cycles, while the Pmc-protected guanidinium side chain prevents side reactions and preserves arginine's basic functionality until late-stage deprotection. The OPfp ester at the C-terminus can participate in acyl transfer to form the next amide linkage, supporting incorporation of a stereodefined arginine residue in peptide building block preparation. The resulting protected peptide segments can be carried forward into longer-chain assembly, enabling structurally defined peptide analog construction and controlled deprotection for final guanidine presentation.
2. Side-Chain Functionalization
Fmoc-Arg(Pmc)-OPfp supports side-chain functionalization strategies that rely on orthogonal protection of the arginine guanidine for selective manipulation. The Pmc-protected guanidinium group is designed to remain masked during coupling and many intermediate transformations, while still enabling later unmasking to regenerate the strongly basic functionality for conjugation or binding-site engineering. The activated OPfp ester functionality facilitates conversion into peptide-linked intermediates that can then be subjected to downstream modifications after guanidine deprotection. Guanidine availability after deprotection can be leveraged for salt-bridge formation, nucleophilic/coordination behavior in synthetic design, and controlled installation of functional groups for biochemical research intermediate generation.
3. Bioconjugation Chemistry
Fmoc-Arg(Pmc)-OPfp is applicable to bioconjugation chemistry when arginine-containing linkers or peptide handles are needed to interface biomolecules with defined charge and recognition properties. The protected guanidine provided by the Pmc group helps avoid uncontrolled reactions during assembly of peptide conjugation scaffolds, while the Fmoc protection supports stepwise construction of conjugatable peptide segments. The OPfp-activated carboxyl functionality can be used to generate peptide-linked intermediates that later undergo deprotection to expose the guanidinium group for conjugation-compatible coupling steps. The stereochemically defined arginine residue and the orthogonal protection pattern support reproducible linker architecture for chemical biology studies and biomolecule modification workflows.
4. Peptidomimetics And SAR
Fmoc-Arg(Pmc)-OPfp is employed in peptidomimetic and SAR studies where incorporation of an arginine residue with controlled guanidine presentation is required to probe structure-function relationships. The Fmoc-protected nitrogen and Pmc-protected guanidine enable synthesis of analog libraries with consistent protection-state control, reducing heterogeneity caused by premature side-chain reactivity. The OPfp ester supports formation of amide bonds that anchor arginine in constrained peptide-like scaffolds, supporting systematic variation of neighboring residues or backbone modifications. Deprotection strategies can then reveal the guanidinium functionality for studying charge-dependent binding motifs and for generating defined chemical entities used in molecular design and applied peptide science.
5. Process Chemistry Intermediate
Fmoc-Arg(Pmc)-OPfp can serve as a process chemistry intermediate for manufacturing peptide building blocks where activated amino acid esters and orthogonally protected side chains improve route control. The OPfp ester form supports efficient coupling chemistry in protected amino acid synthesis, while the Fmoc and Pmc groups provide protection orthogonality that can be aligned with scalable deprotection and purification steps. The arginine stereocenter and the masked guanidine reduce variability in intermediate handling, supporting consistent downstream assembly of protected peptide segments. The compound's defined functional group set makes it suitable for fine chemical synthesis planning, including batch preparation of arginine-containing fragments used in larger peptide manufacturing campaigns.
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. TMEM16F and dynamins control expansive plasma membrane reservoirs
5. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.